Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.75B P/E - EPS this Y 300.00% Ern Qtrly Grth -
Income 18.1M Forward P/E -139.67 EPS next Y 68.20% 50D Avg Chg -4.00%
Sales 1.07B PEG 0.92 EPS past 5Y - 200D Avg Chg 1.00%
Dividend N/A Price/Book 5.61 EPS next 5Y 94.90% 52W High Chg -32.00%
Recommedations 2.40 Quick Ratio 2.14 Shares Outstanding 208.07M 52W Low Chg 109.00%
Insider Own 11.93% ROA 2.17% Shares Float 187.18M Beta 1.05
Inst Own 66.68% ROE 5.31% Shares Shorted/Prior 26.54M/23.04M Price 8.38
Gross Margin 82.19% Profit Margin 1.70% Avg. Volume 3,115,700 Target Price 21.93
Oper. Margin 3.49% Earnings Date Nov 4 Volume 3,028,431 Change -4.34%
About Hims & Hers Health, Inc.

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health, Inc. News
11/22/24 3 US Growth Companies With High Insider Ownership Seeing Up To 40% Earnings Growth
11/21/24 Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
11/20/24 Guardant Health Stock Sees RS Rating Jump To 83
11/18/24 Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
11/15/24 Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally
11/14/24 Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments
11/13/24 Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision
11/13/24 Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
11/12/24 Hims & Hers Health's (NYSE:HIMS) Strong Earnings Are Of Good Quality
11/06/24 Hims & Hers Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
11/05/24 IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory
11/05/24 Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories
11/05/24 Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims
11/04/24 Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences.
11/04/24 Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
10/29/24 How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
10/27/24 Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage
10/22/24 Define Ventures Appoints Bruce Broussard as Venture Partner
10/21/24 Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug
10/21/24 Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
HIMS Chatroom

User Image LoverGirl Posted - 46 minutes from now

$HIMS When $60?? Next summer ?

User Image Fast0rer Posted - 1 hour ago

$HIMS The 1 year old article that was recycled by MSM to help shorters from exiting their positions (imo), approximately 1 week ago, has only brought more investors from Amazon stock to HIMS. Raising the awareness of this stock and potentially tens of millions of buy orders more for the stock & actual customers. Every time they try to 'kill' it, HIMS just comes back stronger and better. It's a beast. Even negative articles have a positive effect on the stock, keep that in mind.

User Image trading_momentum Posted - 3 hours ago

$HIMS premium collected

User Image Riverboatgambler Posted - 4 hours ago

$HIMS isn’t PE ratio getting a little high?

User Image Randymarsh710 Posted - 4 hours ago

$HIMS 32$ then back to 21$ then moon

User Image DonGG Posted - 5 hours ago

$HIMS @Macasdude brokie where are you

User Image EliteOptionsAlaska Posted - 5 hours ago

$HIMS most monthly volume ever and we still have a week left 😳

User Image Marconzi Posted - 5 hours ago

$HIMS 32.5 then 45$. C&H. At neckline on handle.

User Image WhyNotAllin Posted - 6 hours ago

$HIMS what a freakin week. I love this stock!

User Image trading_momentum Posted - 7 hours ago

$HIMS Watch for a breakout and move above 24.6 and I think HIMS will make a strong push to 26, 27.6, and 29.1 respectively. SL depends on your risk tolerance but would suggest ~20% or a daily close belo 20 day SMA (currently 22.6). See chart for more details.

User Image trading_momentum Posted - 7 hours ago

$HIMS Analysis and Setup I really like the look of HIMS for a fresh breakout attempt on this multi-year supply zone. More recently a nice bullish consolidation pattern has formed on this supply zone and we had a strong recovery after our last test into the $30 range which happened earlier this month.

User Image ThePumpFather Posted - 7 hours ago

$HIMS shorts will have to ...

User Image AMUNRATHEBLACKGOD Posted - 8 hours ago

$HIMS Your passive-aggressive ahort-selling ass did!

User Image Dark_Horse_Investments Posted - 8 hours ago

ha ! did not think my personal take would cause such a stir. will not provide my view on $HIMS. I just happened to underwrite the risk (the co came out of private equity - in which we were investors). I like what in my view are long term sustainable businesses with clearly defensible positions. I cannot argue very nice trade. Good luck longs.

User Image Starfish2024 Posted - 8 hours ago

$HIMS people that short this stock are probably in disbelief why this stock continues to go up. “WhY?! ITs JuSt a AnOtHeR Ed cOmpaNY”but we know why ;) have a good weekend everyone!

User Image Scoobysmokesdoobies Posted - 8 hours ago

$HIMS The numbers from this last quarter speak for themselves let the speculators speculate while we accumulate.

User Image Dark_Horse_Investments Posted - 8 hours ago

$HIMS okie does happy to pass good luck again I am not arguing about the caliber of management based on some meme stock dynamics. I have stated there is a trade here not sure this is a lasting model I want to participate or own. There many companies I pass - only own 12 names tops. Be well

User Image Starfish2024 Posted - 8 hours ago

$HIMS @Dark_Horse_Investments I don’t know too many companies that can replicate the management team HiMS has and the ones that do, just go look at their stock.

User Image JordieBelfort Posted - 9 hours ago

$HIMS Expecting a small pull back next week before next leg up. Need to rotate to semis and mag 7. Everyone get to eat!

User Image Starfish2024 Posted - 9 hours ago

$HIMS if people want to sell or short the company because of GLP be my guest, I’m glad grabbing as many shares as I can knowing HIMS is more than GLP-1

User Image Dark_Horse_Investments Posted - 9 hours ago

$HIMS yes i do study financial statements, forensic accountant this is a highly replicable business model i stay away from retail indefensible biz models i am happy for all of you who profit here current price / earnings expectations largely rest on glp1 shortages (hence their dynamic glp1 shortages they just launched). they depend on outside their control factors. as soon as glp1 manufacturing comes inline, government shutting down alternative glp1 generic formulations (underway) combined with lowering of glp1 pricing (too much heat on them) i would not feel comfortable owning hims. I am happy to pass.

User Image Scarthatassup Posted - 9 hours ago

$HIMS this is an insane take. Do you not read financial statements!??

User Image Kiarafanelli8 Posted - 9 hours ago

$HIMS May the force be with Us 📈

User Image gpaisa Posted - 9 hours ago

$HIMS literal v lol. ATH weekly close.

User Image JFDI Posted - 9 hours ago

$HIMS FuLL SEND IT! HF @gpaisa

User Image Dark_Horse_Investments Posted - 9 hours ago

$HIMS There is a trade here. This is definitely a commercial shop, predicated on selling a few cheap generic products, advertising on personalized care. More specifically, it's been riding the bus of glp1 (generic fat reducing injections). There is a trade but eventually reality will show its face (unless, they actually create a unique product)... I see costplusdrugs from Mark Cuban giving it a world of pain, as well as amazon pharmacy and others. I am not long here - underwrote the risk and passed - to me management resembles more a snake-oil-salesmen pit than a knowledgeable experienced pharma team (it has the ring of avon & amway, ponzi schemes). All I am say is beware. Good luck here. This is a ride i am happy to decline.

User Image Rasgulla Posted - 9 hours ago

$HIMS 27% up since then 😂

User Image Hkaz34 Posted - 9 hours ago

@GXD_Texas @Stonks_2_The_Moon I own both $HIMS and RCAT. Your insult shows your ignorant of HIMS model. HIMS is revolutionizing healthcare as we speak. Keep your eyes open. It will be $100 billion company before you blink.

User Image Clargy Posted - 9 hours ago

$HIMS Heavy accumulation over the last few months leading into an ATH break. Let's see it happen.

User Image enchbyench Posted - 9 hours ago

$HIMS me this weekend chillin. @squueeze Mom is just off picture lol

Analyst Ratings
B of A Securities Buy Sep 13, 24
Needham Buy Aug 22, 24
Deutsche Bank Hold Aug 7, 24
Piper Sandler Neutral Aug 6, 24
Truist Securities Hold Jul 18, 24
TD Cowen Buy Jul 11, 24
Piper Sandler Neutral Jul 11, 24
Jefferies Hold Jun 27, 24
B of A Securities Buy Jun 13, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jan 25 Sell 9.06 195,728 1,773,296 51,653 01/29/24
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jan 25 Option 2.43 195,728 475,619 66,753 01/29/24
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Dec 27 Sell 9.03 54,882 495,584 51,653 12/29/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Dec 27 Option 2.43 54,882 133,363 73,085 12/29/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Nov 30 Sell 9.02 28,100 253,462 12/15/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Nov 30 Option 2.43 28,100 68,283 24,300 12/15/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Dec 04 Sell 8.87 27,399 243,029 382,574 12/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Dec 04 Option 0.4 3,624 1,450 407,473 12/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Nov 06 Sell 6.83 27,399 187,135 403,849 11/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Nov 06 Option 0.4 27,399 10,960 412,982 11/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Oct 05 Sell 6.2309 9,133 56,907 403,849 10/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Oct 03 Sell 6.25 18,266 114,162 412,982 10/06/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Sep 20 Sell 6.27 15,504 97,210 168,089 09/22/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Sep 20 Sell 6.28 6,794 42,666 150,982 09/22/23
O'Keefe Lynne Chou Director Director Sep 19 Sell 6.31 10,045 63,384 09/20/23
Becklund Irene PAO PAO Sep 19 Sell 6.31 10,596 66,861 5,494 09/20/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Sep 01 Sell 6.85 27,399 187,683 399,352 09/06/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Aug 21 Sell 6.9154 6,698 46,319 125,016 08/22/23
O'Keefe Lynne Chou Director Director Aug 09 Sell 7.15 45,748 327,098 08/16/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Aug 08 Sell 9.04 6,900 62,376 08/09/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Aug 08 Option 2.43 6,900 16,767 6,900 08/09/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 06 Sell 8.68 9,133 79,274 454,150 07/10/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 06 Option 0.4 9,133 3,653 463,283 07/10/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 03 Sell 9.03 18,266 164,942 454,150 07/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jul 03 Option 0.4 18,266 7,306 463,283 07/06/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 06 Sell 9.13 71,933 656,748 385,947 06/08/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 06 Option 2.43 73,942 179,679 457,880 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jun 06 Sell 9.1 18,266 166,221 422,260 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Jun 06 Option 0.4 11,614 4,646 431,393 06/08/23
Dudum Andrew Chief Executive Offi.. Chief Executive Officer Jun 02 Sell 9.0359 2,009 18,153 383,938 06/08/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 09 Sell 10.78 12,966 139,773 422,579 05/11/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 09 Option 0.4 25,932 10,373 435,545 05/11/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 05 Sell 11.93 31,998 381,736 403,547 05/09/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer May 05 Option 0.4 19,032 7,613 422,579 05/09/23
Becklund Irene PAO PAO Apr 04 Sell 10.3 15,890 163,667 04/06/23
Becklund Irene PAO PAO Apr 04 Option 1.75 567 992 567 04/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Apr 04 Sell 10 30,065 300,650 445,778 04/06/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Mar 20 Sell 9.542 9,333 89,055 475,843 03/21/23
Baird Melissa Chief Operating Offi.. Chief Operating Officer Mar 16 Sell 9.91 22,119 219,199 485,176 03/20/23
Becklund Irene PAO PAO Mar 17 Sell 9.79 6,170 60,404 15,323 03/20/23
Okupe Oluyemi Chief Financial Offi.. Chief Financial Officer Mar 17 Sell 9.9 15,720 155,628 99,013 03/20/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Mar 17 Sell 9.79 13,745 134,564 168,089 03/20/23
Maltz Jules A. 10% Owner 10% Owner Mar 02 Sell 10.1 36,820 371,882 03/06/23
Bard Alex Director Director Mar 01 Sell 11.17 2,819,109 31,489,448 7,349,710 03/03/23
Boughton Soleil Chief Legal Officer Chief Legal Officer Jan 17 Sell 7.51 2,000 15,020 287,089 01/19/23
O'Keefe Lynne Chou Director Director Sep 20 Sell 5.68 10,046 57,061 09/21/22
Becklund Irene PAO PAO Sep 20 Sell 5.68 10,668 60,594 6,978 09/21/22
Becklund Irene PAO PAO Jul 05 Sell 5 19,331 96,655 13,717 07/06/22
O'Keefe Lynne Chou Director Director Jun 21 Sell 4.35 10,045 43,696 06/22/22
Maltz Jules A. Director Director Jun 14 Buy 3.66 75,000 274,500 125,000 06/16/22